Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol pilot trial for severe behavioural problems in children with intellectual disability
ACTRN12618001852246Phase 2Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in intellectual disability (ID) comparing Cannabidiol with Placebo (2 arms). Primary endpoints: Recruitment feasibility, Acceptability of study procedures and 1 more. Started Jan 2019; status: completed.
02
Drugs
cannabidiol
03
Conditions
intellectual disability (ID)
Beyond the preview
Go deeper on ACTRN12618001852246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001852246.